Skip to content

13F-HR filed by TPG GP A, LLC

TPG GP A, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 9 holding rows worth $1,876,001,628.

Accession
0001999371-25-011364
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A combination report, 9 entries on the cover page, a total value of $1,876,001,628 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,876,001,628 with VALUE read as dollars as filed, 13F file number 028-22121. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerAngelo Gordon & Co., L.P. 028-02616

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LIFESTANCE HEALTH GROUP INC53228F101COM160,711,618$830,879,065dollars as filed
LIFE TIME GROUP HOLDINGS INC COMMON STOCK53190C102Stock21,404,488$649,198,121dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK6,744,962$117,025,091dollars as filed
AMNEAL PHARMACEUTICALS INC03168L105COM STK CL A12,328,767$99,739,725dollars as filed
CERIBELL INC15678C102COMMON STOCK3,967,422$74,309,814dollars as filed
TPG RE FIN TR INC COM87266M107REIT7,086,779$54,709,934dollars as filed
BICARA THERAPEUTICS INC055477103COM3,010,425$27,966,848dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM18,716,306$21,149,426dollars as filed
RALLYBIO CORP75120L100COM3,028,414$1,023,604dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001999371-25-011364this filing2025-08-14acceptance time not in the bulk data set